The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma.
 
Thejus Jayakrishnan
No Relationships to Disclose
 
Yasmine Baca
Employment - Caris Life Sciences
 
Joanne Xiu
Employment - Caris Life Sciences
 
Mehrie Patel
No Relationships to Disclose
 
Benjamin Adam Weinberg
Employment - Apple (I)
Stock and Other Ownership Interests - Apple (I)
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bayer; DoMore Diagnostics; HalioDx; Merus NV
Speakers' Bureau - Bayer; Daiichi Sankyo/Astra Zeneca; HalioDx; Lilly; Merus NV; Seagen; Sirtex Medical; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); BioXCell (Inst); Immune System Key (Inst); Ipsen (Inst); Isofol Medical (Inst); Merck (Inst); Novartis (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Boehringer Ingelheim; Caris Life Sciences; Merus NV
 
Emil Lou
Honoraria - Boston Scientific; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Intima; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
Jashodeep Datta
No Relationships to Disclose
 
Moh'd M. Khushman
Stock and Other Ownership Interests - Blueprint Medicines; Cardiff Oncology; Moderna Therapeutics; Regeneron
Speakers' Bureau - Caris Life Sciences
 
Pat Gulhati
No Relationships to Disclose
 
Sanjay Goel
Stock and Other Ownership Interests - Johnson and Johnson; Merck; Moderna Therapeutics
Honoraria - Amgen; Merck
Research Funding - BeiGene (Inst); Deciphera (Inst); Dragonfly Therapeutics (Inst); EMD Serono (Inst); PharmaMar (Inst); Takeda (Inst); TLC PharmaChem (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364
 
Tiago Biachi de Castria
Consulting or Advisory Role - AstraZeneca; Bayer; MSD Oncology
Speakers' Bureau - AstraZeneca; Bristol Myers Squibb Foundation; Lilly; MSD; Roche; SERVIER
Travel, Accommodations, Expenses - A2 Biotherapeutics
 
Vaia Florou
Consulting or Advisory Role - Deciphera; Incyte
 
Kanika G. Nair
No Relationships to Disclose
 
Suneel Deepak Kamath
Consulting or Advisory Role - Exelixis; Foundation Medicine; Guardant Health; Seagen; Tempus
Speakers' Bureau - Merck; Seagen
 
Alok A. Khorana
Honoraria - Anthos Therapeutics; Bayer; BMS; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Anthos Therapeutics; Bayer; BMS; Janssen; Pfizer; Sanofi
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Leap Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Janssen